ClinicalTrials.Veeva
Menu

Find clinical trials for Glioblastoma (GBM) in Kansas City, KS

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Glioblastoma
Recurrence
Brain Cancer
Glioma
Astrocytoma
Cancer
Gliosarcoma

Glioblastoma (GBM) trials near Kansas City, KS, USA:

Study of a Drug [DCVax®-L] to Treat Newly Diagnosed GBM Brain Cancer

The primary purpose of the study is to determine the efficacy of an investigational therapy called DCVax(R)-L in patients with newly diagnosed GBM...

Active, not recruiting
Glioblastoma
Glioblastoma Multiforme
Drug: Dendritic cell immunotherapy

Phase 3

Northwest Biotherapeutics
Northwest Biotherapeutics

Kansas City, Missouri, United States and 85 other locations

In summary, standard of care postoperative chemoradiation for patients with newly diagnosed GBM does not routinely provide durable local con...

Enrolling
Glioblastoma
Device: Surgical tumor resection, GammaTile radiation therapy implantation, Stupp protocol (EBRT and Temozolamide)

Phase 4

GT Medical Technologies

Kansas City, Kansas, United States and 10 other locations

therapy alone as a treatment for newly diagnosed MGMT unmethylated glioblastoma patients. The patients' own cancer cells collected after sur...

Enrolling
Glioblastoma Multiforme of Brain
Biological: TVI-Brain-1
Procedure: Standard of Care

Phase 2, Phase 3

TVAX Biomedical

Kansas City, Kansas, United States and 4 other locations

To test the effectiveness and safety of Optune® given concomitantly with radiation therapy (RT) and temozolomide (TMZ) in newly diagnosed GBM...

Active, not recruiting
Glioblastoma Multiforme
Device: Optune®
NovoCure
NovoCure

Kansas City, Missouri, United States and 132 other locations

receptor (EGFR) resistance (EGFR C797S) mutations with or without CNS disease (in Phase 1 and Phase 2), or glioblastoma (GBM) expr...

Enrolling
Advanced Non-Small Cell Squamous Lung Cancer
Epidermal Growth Factor Receptor C797S
Drug: BDTX-1535 monotherapy

Phase 1, Phase 2

Black Diamond Therapeutics

Kansas City, Kansas, United States and 24 other locations

This clinical trial is testing the safety and efficacy of NanO2TM administered via intravenous infusion in combination with standard radiation and ch...

Enrolling
Glioblastoma Multiforme
Drug: Placebo Saline Infusion
Drug: NanO2TM

Phase 2

NuvOx Pharma

Kansas City, Missouri, United States and 8 other locations

This Global Phase 3 study aims to find out whether RRx-001 + platinum chemotherapy is more effective than platinum chemotherapy alone in 3rd line or...

Enrolling
Carcinoma, Small Cell Lung
Drug: RRx-001 + eLOOP Device
Drug: Cisplatin/carboplatin plus etoposide

Phase 3

EpicentRx
EpicentRx

Westwood, Kansas, United States and 2 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems